Milestone Scientific (MLSS) Cash from Financing Activities (2011 - 2026)
Milestone Scientific (MLSS) reported Cash from Financing Activities of -$3428.0 for Q1 2026, down 50.48% on a YoY basis from -$6922.9 in Q1 2025, and little changed sequentially from -$3414.0 in Q4 2025.
Milestone Scientific (MLSS) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Milestone Scientific (MLSS) has 15 years of Cash from Financing Activities data on file, last reported at -$3428.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 50.48% year-over-year to -$3428.0; the trailing twelve-month figure through Mar 2026 stood at $785185.0 (up 8002.43% YoY), and the FY2025 full-year result was $786335.0, up 236.37% from the prior year.
- Cash from Financing Activities was little changed at -$3428.0 in Q1 2026, from -$3414.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $2.6 million in Q4 2023 to a low of -$4556.0 in Q3 2025.
- A 5-year average of $209933.5 and a median of -$2171.0 in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 102.87% in 2022 and soared 124843.49% in 2023, its largest moves.
- Tracing MLSS's Cash from Financing Activities over 5 years: stood at -$2058.0 in 2022, then soared by 124843.49% to $2.6 million in 2023, then sank by 100.1% to -$2523.0 in 2024, then plunged by 35.32% to -$3414.0 in 2025, then slipped by 0.41% to -$3428.0 in 2026.
- Business Quant data shows MLSS's Cash from Financing Activities at -$3428.0 in Q1 2026, -$3414.0 in Q4 2025, and -$4556.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Milestone Scientific | 33.00 Mn | 31.35 Mn | 1.56 Mn | -3,428.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,428.00 |
| Mar 31, 2026 | -3,428.00 |
| Dec 31, 2025 | -3,414.00 |
| Dec 31, 2025 | -3,414.00 |
| Sep 30, 2025 | -4,556.00 |
| Sep 30, 2025 | -4,556.00 |
| Jun 30, 2025 | 796,583.00 |
| Jun 30, 2025 | 796,583.00 |
| Mar 31, 2025 | -2,278.00 |
| Mar 31, 2025 | -2,278.00 |
| Dec 31, 2024 | -2,523.00 |
| Dec 31, 2024 | -2,523.00 |
| Sep 30, 2024 | -2,595.00 |
| Sep 30, 2024 | -2,595.00 |
| Jun 30, 2024 | -2,540.00 |
| Jun 30, 2024 | -2,540.00 |
| Mar 31, 2024 | 241,429.00 |
| Mar 31, 2024 | 241,429.00 |
| Dec 31, 2023 | 2.57 Mn |
| Dec 31, 2023 | 2.57 Mn |